NPR
Shots - Health News NPR's online health program.
Shots
Health News From NPRDont Miss
A pre-pandemic Seattle supermarket boasts row after row of prepackaged snacks. Even before the coronavirus pandemic put extra stress on grocery workers, keeping shelves stocked with the variety that Americans have come to expect took a hidden toll on producers, distributors and retail workers, says author Benjamin Lorr.David Ryder/Getty Imageshide caption
Jasmin Merdan/Getty Images
Health care professionals gather outside Barnes-Jewish Hospital in St. Louis in June to demonstrate in support of the Black Lives Matter movement.Jeff Roberson/APhide caption
A worker passes through the security gate at the Moderna campus in Norwood, Mass., one of the sites where the biotechnology company is manufacturing its COVID-19 vaccine. Joseph Prezioso/AFP via Getty Images hide caption
A health care worker prepares COVID-19 vaccine doses at the Portland Veterans Affairs Medical Center on Wednesday in Portland, Ore. Hospitals across the U.S. began getting their first doses of Pfizer's vaccine this week. Nathan Howard/Getty Images hide caption
Without Resources, Vaccine Rollout Could 'Fall At The Last Hurdle,' Journalist Warns
A COVID-19 vaccine made by Moderna is next in line with the Food and Drug Administration for possible authorization for emergency use during the pandemic. Bill Sikes/AP hide caption
A paramedic uses a pulse oximeter to check a patient's vital signs during an August home visit in the Bronx borough of New York. Angus Mordant/Bloomberg via Getty Images hide caption
An American flag with an image of a Native American on it in To'Hajiilee Indian Reservation in New Mexico. In California, a vaccine allocation committee is considering taking historical injustice into account in advance of a statewide rollout. Sam Wasson/Getty Images hide caption
California May Consider 'Historical Injustice' When Allocating COVID-19 Vaccine
A new at-home test for the coronavirus has been approved by the U.S. Food and Drug Administration. The test will cost about $30 and will be available over-the-counter, according to the company who makes it, Ellume. Ellume Health hide caption
FDA Authorizes 1st Home Coronavirus Test That Doesn't Require A Prescription
Moderna is making its COVID-19 vaccine at a company factory in Norwood, Mass. Joseph Prezioso/AFP via Getty Images hide caption
Victoria Gray (second from left) with children Jamarius Wash, Jadasia Wash and Jaden Wash. Now that the gene-editing treatment has eased Gray's pain, she has been able be more active in her kids' lives and looks forward to the future. "This is really a life-changer for me," she says. Victoria Gray hide caption
1st Patients To Get CRISPR Gene-Editing Treatment Continue To Thrive
White flags planted by volunteers visualize lives lost in the U.S. to COVID-19 as part of an installation by artist Suzanne Firstenberg in Washington, D.C. The death toll has now reached 300,000. Roberto Schmidt/AFP via Getty Images hide caption
Howard Berkes (seated, front row right) volunteered to be part of a COVID-19 research study this year. He says his family, photographed here in the 1960s, had a history of stepping up during difficult times. That includes his grandparents (in middle), who fled the pogroms of Eastern Europe in the 1920s to raise a family in the United States. Berkes family hide caption
Following similar decisions in the United Kingdom and Canada, the U.S. has authorized the Pfizer-BioNTech vaccine for distribution. Matthew Horwood/Getty Images hide caption
Pfizer-BioNTech's COVID-19 vaccine has been tested for safety and efficacy in more than 44,000 people. Still, stopping viral spread will take more than immunizations, says the CDC. The agency is calling for those who are vaccinated to continue wearing masks and practicing safe physical distancing. Frank Augstein/AP hide caption
Software engineer Adriana Kaplan outside her home in South Philadelphia. Kimberly Paynter/WHYY hide caption
Without Clear Pandemic Rules, People Take On More Risks As Fear And Vigilance Wane
Lisa Taylor got a COVID-19 vaccination in August as part of a vaccine study at Research Centers of America in Hollywood, Fla. Joe Raedle/Getty Images hide caption
A panel of advisers to the Food and Drug Administration met Thursday to evaluate Pfizer and BioNTech's COVID-19 vaccine and make recommendations on emergency use to the agency. A quick FDA decision is expected after the advisers' 17-4 vote. Jacquelyn Martin/AP hide caption
A vial of the COVID-19 vaccine developed by Pfizer and BioNTech that was used at the Royal Victoria Hospital in Belfast, U.K., on Tuesday. Liam McBurney/Bloomberg via Getty Images hide caption
Root extracts from the African shrub iboga have long been used in traditional healing rituals and more recently as an experimental treatment for depression and to reduce drug cravings in addiction. Scientists now are working on a version of the extract that doesn't cause heart attacks or hallucinations as side effects. Steeve Jordan/AFP via Getty Images hide caption